Search Results - "Zanchetta, M.B"

Prevalence of secondary causes in a population of premenopausal women with low bone mass by Farias, V.S, Zanchetta, M.B

Get full text

Multiple secondary fractures to treatment with adefovir by Zanchetta, M.B, Paz Wasiuchnik, V, Abdala, R

Get full text

Effect of Denosumab on bone mineral density and markers of bone turnover by Sánchez, A, Brun, L.R, Salerni, H, Costanzo, P, Zanchetta, M.B, Farías, V, Maffei, L, Premrou, V, Larroudé, M.S, Sarli, M.A, Rey, P, Brance, M.L, Pavlove, M.M, Karlsbrum, S

Get full text

Densitometric response in postmenopausal osteoporosis treated with strontium ranelate or denosumab by Sánchez, A, Brun, L.R, Salerni, H, Costanzo, P, Maffei, L, Premrou, V, Sarli, M.A, Rey, P, Larroudé, M.S, Brance, M.L, Galich, A.M, Vega, E, Zanchetta, M.B, Farías, V, Moggia, M.S, Pavlove, M.M, Karlsbrum, S

Get full text

Differences in microarchitecture parameters of bone quality in low and high turnover renal osteodystrophy assessed by HR-pQCT by Negri, A.L, Del Valle, E.E, Zanchetta, M.B, Silveira, F, Bogado, C.E, Zanchetta, J.R

Get full text

High-Resolution Peripheral Quantitative Computerized Tomography (HR-pQCT) Describes Characteristics of Bone Fragility in Premenopause Celiac Disease Patients by Zanchetta, M.B, Longobardi, V, Costa, F, Bai, J.C, Silveira, F, Vazquez, H

Get full text

Two cases of pregnancy- and lactation-associated osteoporosis successfully treated with denosumab by Sánchez, A., Zanchetta, M.B., Danilowicz, K.

Get full text

Asymptomatic elevated parathyroid hormone level due to immunoassay interference by Zanchetta, M.B., Giacoia, E., Jerkovich, F., Fradinger, E.

“…Background Parathyroid hormone (PTH) measurement using immunoassays is inherently vulnerable to interferences due to the presence of different proteins such as…”
Get full text

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis by Farías, V., Maffei, L., Premrou, V., Larroudé, M. S., Sarli, M. A., Rey, P., Ulla, M. R., Pavlove, M. M., Karlsbrum, S., Brance, M. L., Zanchetta, M. B., Oliveri, B., Bagur, A., González, D., Costanzo, Pablo R., Salerni, H., Brun, L. R., Sánchez, A., Mansur, J. L.

“…The aim of this study was to evaluate the effect of denosumab (Dmab) on bone mineral density (BMD) and bone turnover markers after 1 year of treatment…”
Get full text

Denosumab: an update by Bogado, Cesar E, Boailchuk, J A, Zanchetta, M B, Massari, F E, Zanchetta, J R

“…Denosumab is a fully human monoclonal antibody that inhibits the formation, function and survival of osteoclasts, preventing the interaction of tumor necrosis…”
Get full text